Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease

This publication has 25 references indexed in Scilit:

• Effective control of refractory pulmonary hypertension after cardiac operations
  The Journal of Thoracic and Cardiovascular Surgery, 1997
• Rebound Pulmonary Hypertension After Inhalation of Nitric Oxide
  The Annals of Thoracic Surgery, 1996
• The use of phosphodiesterase inhibitor (dipyridamole) to wean from inhaled nitric oxide
  Intensive Care Medicine, 1996
• Atrial natriuretic peptide and nitric oxide in children with pulmonary hypertension after surgical repair of congenital heart disease
  The American Journal of Cardiology, 1996
• Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance.
  Journal of Clinical Investigation, 1995
• Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure
  The Journal of Pediatrics, 1994
• Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide
  The Journal of Pediatrics, 1993
• Inhaled Nitric Oxide for the Adult Respiratory Distress Syndrome
  New England Journal of Medicine, 1993
• Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension.
  Circulation, 1982
• Inhibition of hypoxic pulmonary vasoconstriction by dipyridamole is not platelet mediated
  Canadian Journal of Physiology and Pharmacology, 1977